VP, Regulatory Affairs
Jenny Swalec serves as vice president of regulatory affairs at Paragon Biosciences. She is responsible for regulatory submissions and interactions with global health authorities.
Jenny Swalec has over 25 years of regulatory affairs experience. Previously, she was vice president of regulatory affairs at Castle Creek Pharmaceuticals, a Paragon portfolio company. Ms. Swalec served in the same role at Marathon Pharmaceuticals and as senior director of global regulatory affairs at Lundbeck. She began her career as manager of regulatory affairs at Parke Davis. Ms. Swalec earned a bachelor’s degree in biology and chemistry from Eastern Michigan University.